PARP1 and cardiac hypertrophy: To investigate whether SIRT3 inhibits cardiac hypertrophy by inhibiting PARP-1 activity, we overexpressed SIRT3 in cardiomyocytes with Ad-SIRT3, then stimulate with ISO or PE for 24 h, and detect PARP-1 activity changes with anti-PAR antibody.